Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region. We are committed to delivering minimally invasive surgical technologies that enhance patient clinical care while providing sustained value for our customers. We currently market the AxiaLIF® family of products for single and two level lumbar fusion, the VEOTM lateral access and interbody fusion system, the Vectre™lumbar posterior fixation system and Bi-OsteticTM bone void filler, a biologics product. Our AxiaLIF products use our pre-sacral approach, through which a surgeon can access discs in the lumbar region of the spine through an incision adjacent to the tailbone and perform an interbody fusion procedure through instrumentation that provides direct access to the intervertebral space. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.78 |
| Quarterly EPS Est: | -0.16 |
| PEG Ratio: | .00 |
|
Mean Recommendation: View Summary / View All |
1.29 |
Data is provided by Zacks Investment Research

